ATE169823T1 - Bradykinin typische peptide - Google Patents
Bradykinin typische peptideInfo
- Publication number
- ATE169823T1 ATE169823T1 AT92911377T AT92911377T ATE169823T1 AT E169823 T1 ATE169823 T1 AT E169823T1 AT 92911377 T AT92911377 T AT 92911377T AT 92911377 T AT92911377 T AT 92911377T AT E169823 T1 ATE169823 T1 AT E169823T1
- Authority
- AT
- Austria
- Prior art keywords
- bradykinin
- antagonists
- phe
- substitution
- produced
- Prior art date
Links
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 title abstract 6
- 101800004538 Bradykinin Proteins 0.000 title abstract 5
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 title abstract 5
- 102400000967 Bradykinin Human genes 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 102100035792 Kininogen-1 Human genes 0.000 abstract 4
- 239000003152 bradykinin antagonist Substances 0.000 abstract 3
- 238000006467 substitution reaction Methods 0.000 abstract 2
- COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical compound OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 208000006877 Insect Bites and Stings Diseases 0.000 abstract 1
- 108010093008 Kinins Proteins 0.000 abstract 1
- 102000002397 Kinins Human genes 0.000 abstract 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical group OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 1
- 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 abstract 1
- FXHCFPUEIDRTMR-UHFFFAOYSA-N hydron;1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid;chloride Chemical compound Cl.C1=CC=C2CNC(C(=O)O)CC2=C1 FXHCFPUEIDRTMR-UHFFFAOYSA-N 0.000 abstract 1
- 229960002591 hydroxyproline Drugs 0.000 abstract 1
- -1 hydroxyproline ethers Chemical class 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 239000000813 peptide hormone Substances 0.000 abstract 1
- 150000003568 thioethers Chemical class 0.000 abstract 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/18—Kallidins; Bradykinins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/807—Hapten conjugated with peptide or protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
- Y10S530/815—Carrier is a synthetic polymer
- Y10S530/816—Attached to the carrier via a bridging agent
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68795091A | 1991-04-19 | 1991-04-19 | |
| US86638592A | 1992-04-14 | 1992-04-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE169823T1 true ATE169823T1 (de) | 1998-09-15 |
Family
ID=27104117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92911377T ATE169823T1 (de) | 1991-04-19 | 1992-04-16 | Bradykinin typische peptide |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6288036B1 (de) |
| EP (1) | EP0618809B1 (de) |
| JP (1) | JP3465000B2 (de) |
| AT (1) | ATE169823T1 (de) |
| AU (1) | AU1914592A (de) |
| CA (1) | CA2106768C (de) |
| DE (1) | DE69226708T2 (de) |
| ES (1) | ES2123556T3 (de) |
| IE (1) | IE921297A1 (de) |
| IL (1) | IL101649A (de) |
| NZ (1) | NZ242447A (de) |
| WO (1) | WO1992018155A1 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0618810B1 (de) * | 1991-04-19 | 2001-07-04 | Scios Nova Inc. | Peptidantagonisten des bradykinin |
| US5686565A (en) * | 1992-10-08 | 1997-11-11 | Scios Inc. | Bradykinin antagonist pseudopeptide derivatives of aminoalkanoic acids and related olefins |
| US5541286A (en) * | 1992-10-08 | 1996-07-30 | Scios Nova Inc. | Bradykinin antagonist pseudopeptide derivatives of olefinic aminoalkanoic acids |
| WO1994019372A1 (en) * | 1993-02-17 | 1994-09-01 | Scios Nova Inc. | Cyclic bradykinin antagonist peptides |
| US5817756A (en) * | 1993-09-09 | 1998-10-06 | Scios Inc. | Pseudo- and non-peptide bradykinin receptor antagonists |
| DE4345062A1 (de) * | 1993-12-31 | 1995-07-13 | Hoechst Ag | Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von Viruserkrankungen |
| AU696429B2 (en) * | 1994-03-09 | 1998-09-10 | Cortech, Inc. | Bradykinin antagonist peptides incorporating n-substituted glycines |
| US6869023B2 (en) * | 2002-02-12 | 2005-03-22 | Digimarc Corporation | Linking documents through digital watermarking |
| DE19612067A1 (de) * | 1996-03-27 | 1997-10-02 | Hoechst Ag | Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen |
| US7041785B1 (en) | 1996-08-19 | 2006-05-09 | UNIVERSITé DE SHERBROOKE | B1-bradykinin receptor antagonists and use thereof |
| DE19642289A1 (de) | 1996-10-14 | 1998-04-16 | Hoechst Ag | Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung und Prävention der Alzheimer'schen Krankheit |
| US7807629B1 (en) | 2007-06-05 | 2010-10-05 | Alcon Research, Ltd. | Use of bradykinin and related B2R agonists to treat ocular hypertension and glaucoma |
| ES2436550T3 (es) | 2009-04-20 | 2014-01-02 | F. Hoffmann-La Roche Ag | Nuevos derivados de prolina como inhibidores de catepsina |
| CN105085633B (zh) * | 2014-05-12 | 2019-10-08 | 复旦大学 | 具有缓激肽受体结合活性的多肽及其用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1980000252A1 (en) | 1978-07-18 | 1980-02-21 | Kabi Ab | Bradykinin-inhibiting tripeptide derivatives |
| US4483850A (en) * | 1982-05-10 | 1984-11-20 | Merck & Co., Inc. | N-Terminal substituted oligopeptide converting enzyme inhibitors |
| DE3303112A1 (de) | 1983-01-31 | 1984-08-09 | Hoechst Ag, 6230 Frankfurt | Verfahren zur racemattrennung optisch aktiver bicyclischer imino-(alpha)-carbonsaeuren |
| US4801613A (en) | 1985-06-13 | 1989-01-31 | Nova Technology Limited Partnership | Bradykinin antagonist peptides |
| US4693993A (en) | 1985-06-13 | 1987-09-15 | Stewart John M | Bradykinin antagonist peptides |
| US4923963A (en) | 1987-09-02 | 1990-05-08 | Nova Technology Limited Partnership | Bradykinin antagonist peptides |
| IE63490B1 (en) * | 1988-11-24 | 1995-05-03 | Hoechst Ag | Peptides having bradykinin antagonist action |
| DE3926822A1 (de) * | 1989-08-14 | 1991-02-21 | Hoechst Ag | Peptide mit bradykinin-antagonistischer wirkung |
| MX9100717A (es) * | 1990-08-24 | 1992-04-01 | Syntex Inc | Antagonistas de la bradiquinina |
-
1992
- 1992-04-16 CA CA002106768A patent/CA2106768C/en not_active Expired - Lifetime
- 1992-04-16 ES ES92911377T patent/ES2123556T3/es not_active Expired - Lifetime
- 1992-04-16 AU AU19145/92A patent/AU1914592A/en not_active Abandoned
- 1992-04-16 JP JP51139592A patent/JP3465000B2/ja not_active Expired - Lifetime
- 1992-04-16 DE DE69226708T patent/DE69226708T2/de not_active Expired - Fee Related
- 1992-04-16 WO PCT/US1992/003031 patent/WO1992018155A1/en not_active Ceased
- 1992-04-16 AT AT92911377T patent/ATE169823T1/de not_active IP Right Cessation
- 1992-04-16 EP EP92911377A patent/EP0618809B1/de not_active Expired - Lifetime
- 1992-04-19 IL IL10164992A patent/IL101649A/en not_active IP Right Cessation
- 1992-04-22 IE IE129792A patent/IE921297A1/en not_active Application Discontinuation
- 1992-04-22 NZ NZ242447A patent/NZ242447A/en not_active IP Right Cessation
-
1993
- 1993-12-16 US US08/167,051 patent/US6288036B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US6288036B1 (en) | 2001-09-11 |
| DE69226708D1 (en) | 1998-09-24 |
| AU1914592A (en) | 1992-11-17 |
| DE69226708T2 (de) | 1999-04-15 |
| CA2106768A1 (en) | 1992-10-20 |
| IL101649A0 (en) | 1992-12-30 |
| WO1992018155A1 (en) | 1992-10-29 |
| NZ242447A (en) | 1994-06-27 |
| IE921297A1 (en) | 1992-10-21 |
| EP0618809A1 (de) | 1994-10-12 |
| ES2123556T3 (es) | 1999-01-16 |
| IL101649A (en) | 1996-09-12 |
| EP0618809A4 (de) | 1994-07-28 |
| JP2002519993A (ja) | 2002-07-02 |
| JP3465000B2 (ja) | 2003-11-10 |
| CA2106768C (en) | 2000-09-19 |
| EP0618809B1 (de) | 1998-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL101648A0 (en) | Bradykinin antagonist peptides | |
| ATE169823T1 (de) | Bradykinin typische peptide | |
| ES2130265T3 (es) | Region de union al receptor de la toxina difterica. | |
| HUP0002704A2 (hu) | Az 5. és a 6. helyzetben módosított GnRH antagonisták | |
| NZ325060A (en) | Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone | |
| DE69942753D1 (de) | Peptidantagonist von Zonulin und dessen Verwendung | |
| NO982729D0 (no) | Antagonister av det gonadotropinfrigj°rende hormon | |
| DE69925024D1 (de) | Verwendung von eph-rezeptor-antagonisten und agonisten zur behandlung von vaskulären krankheiten | |
| ES2187958T3 (es) | Antagonistas de gnrh. | |
| EA199800564A1 (ru) | Антагонисты гонадотропин-высвобождающего фактора | |
| NL300013I1 (nl) | Nieuwe protein met TNF-remmende werking en hun ber | |
| ATE278708T1 (de) | Conotoxin peptid pviia | |
| ES2112255T3 (es) | Complejos proteicos que tienen actividad del factor viii:c y su produccion. | |
| ATE280777T1 (de) | Bradykinin-antagonist peptide mit n- substituierten glycinen | |
| EP0352014A3 (de) | Zyklische GRF-Analoge | |
| ES2150901T3 (es) | Antagonistas de hormonas del crecimiento. | |
| IL184121A0 (en) | Urotensin-ii agonists polypeptide and its use for manufacture of medicaments | |
| DE60233654D1 (de) | Dimerisierter t-zell rezeptor fragment, dessen zusammensetzungen und verwendung | |
| GB1294771A (en) | Thyrocalcitonin derivative | |
| KR920004417A (ko) | 고나돌리베린 길항물질 | |
| NO941562L (no) | Anvendelse av brandykinin-anatgonister for fremstilling av et medikament for profylakse eller forbehandling av arteriosklerose | |
| ES2061908T3 (es) | Antagonistas competitivos de gonadoliberina. | |
| ES2071120T3 (es) | Control de la secrecion lactea. | |
| ECSP972344A (es) | Proteinas antiobesidad |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |